Lack of serologic evidence of Neospora caninum in Humans, England

Emerging Infectious Diseases

Volumn 14, Issue 6, 2008, Pages 978-980

  McCann, Catherine M ^a   Vyse, Andrew J ^b   Salmon, Roland L ^c   Thomas, Daniel ^c   Williams, Diana J L ^a   McGarry, John W ^a   Pebody, Richard ^b   Trees, Alexander J ^a,d  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c PUBLIC HEALTH WALES   (United Kingdom)

^d LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PHOSPHATE BUFFERED SALINE;

ARTICLE; BLOOD SAMPLING; DIAGNOSTIC PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOFLUORESCENCE TEST; LABORATORY TEST; MEDICAL ETHICS; MORBIDITY; NEOSPORA CANINUM; OPTICAL DENSITY; PROTOZOAL INFECTION; RETROSPECTIVE STUDY; RISK FACTOR; SEROLOGY; UNITED KINGDOM;

EID: 45249115933     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1406.071128     Document Type: Article

References (13)

1. Dubey JP, Schares G, Ortega-Mora LM. Epidemiology and control of neosporosis and Neospora caninum. Clin Microbiol Rev. 2007;20:323-67.
2. Barr BC, Conrad PA, Sverlow KW, Tarantal AF, Hendrickx AG. Experimental fetal and transplacental Neospora infection in the nonhuman primate. Lab Invest. 1994;71:236-42.
3. Osborne K, Gay N, Hesketh L, Morgan-Capner P, Miller E. Ten years of serological surveillance in England and Wales: methods, results, implications and action. Int J Epidemiol. 2000;29:362-8.
4. Thomas DR, Salmon RL, Kench SM, Meadows D, Coleman TJ, Morgan-Capner P, et al. Zoonotic illness - determining risks and measures of effects: association between current animal exposure and a history of illness in a well characterised rural population. J Epidemiol Community Health. 1994;48:151-5.
5. Thomas DR, Salmon RL, Coleman TJ, Morgan-Capner P, Sillis M, Caul EO, et al. Occupational exposure to animals and risk of zoonotic illness in a cohort of farmers, farmworkers and their families in England. In: Hansen PD, editor. Selected peer-review papers from "Rural Health and Safety in a Changing World" Conference. J Agric Saf Health. 2000;5:373-82.
6. McGarry JW, Guy F, Trees AJ, Williams DJL. Validation and application of an inhibition ELISA to detect serum antibodies to Neospora caninum in different host species. In: Hemphill A, Gottstein B, editors. A European perspective on Neospora caninum. Int J Parasitol. 2000;30:877-924.
7. Trees AJ, Guy F, Tennant BJ, Balfour AH, Dubey JP. Prevalence of antibodies to Neospora caninum in a population of urban dogs in England. Vet Rec. 1993;132:125-6.
8. Kelly H, Riddell MA, Gidding HF, Nolan T, Gilbert GL. A random cluster survey and a convenience sample give comparable estimates of immunity to vaccine preventable diseases in children of school age in Victoria, Australia. Vaccine. 2002;20:3130-6.
9. Tranas J, Heinzen RA, Weiss LM, McAllister MM. Serological evidence of human infection with the protozoan Neospora caninum. Clin Diagn Lab Immunol. 1999;6:765-7.
10. Lobato J, Silva DA, Mineo TW, Amaral JD, Segundo GR, Costa-Cruz JM, et al. Detection of immunoglobulin G antibodies to Neospora caninum in humans: high seropositivity rates in patients who are infected by human immunodeficiency virus or have neurological disorders. Clin Vaccine Immunol. 2006;13:84-9.
11. Nam HW, Kang SW, Choi WY. Antibody reaction of human anti-Toxoplasma gondii positive and negative sera with Neospora caninum - specific antibodies in goats from Sri Lanka. Korean J Parasitol. 1998;36:269-75.
12. Graham DA, Calvert V, Whyte M, Marks J. Absence of serological evidence for human Neospora caninum infection. Vet Rec. 1999;144:672-3.
13. Petersen E, Lebech M, Jensen L, Lind P, Rask M, Bagger P, et al. Neospora caninum infection and repeated abortions in humans. Emerg Infect Dis. 1999;5:278-80.